J Neurogastroenterol Motil.  2019 Jan;25(1):148-158. 10.5056/jnm17085.

Differential Effects of Lactobacillus casei Strain Shirota on Patients With Constipation Regarding Stool Consistency in China

Affiliations
  • 1Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China. renfazheng@cau.edu.cn
  • 2Beijing Laboratory for Food Quality and Safety, Beijing, China.
  • 3Key Laboratory of Functional Dairy, College of Food Science and Nutritional Engineering, Beijing, China.
  • 4Science and Public Relations Office, Yakult (China) Corporation, Shanghai, China.
  • 5Beijing Key Laboratory of Detection and Control of Spoilage Organisms and Pesticide Residues in Agricultural Products, Beijing University of Agriculture, Beijing, China.

Abstract

BACKGROUND/AIMS
Probiotics are expected to confer benefits on patients with constipation, but how probiotics act on constipated patients with variable stool consistencies remains unclear. We investigated the effect of Lactobacillus casei strain Shirota (LcS) on constipation-related symptoms, especially stool consistency, of constipated patients.
METHODS
Constipated patients meeting the Rome III criteria were divided into 3 groups according to the Bristol Stool Form Scale (BSFS): hard (hard stool [HS], BSFS < 3), normal (normal stool [NS], ≤ 3 BSFS ≤ 4), and soft (soft stool [SS], 4 < BSFS ≤ 5) stools. Subjects in each group consumed a probiotic beverage containing 1010 colony-forming units of LcS daily for 28 days.
RESULTS
LcS intervention significantly alleviated constipation-related symptoms and increased defecation frequency in all subjects. Four weeks of LcS supplementation softened the hard stools in HS, hardened the soft stools in SS, and did not alter the ideal stool consistency in NS. The short-chain fatty acid (SCFA) concentrations were highest in SS, followed by NS and HS. LcS intervention increased the stool SCFA levels in HS but reduced or did not alter the levels in NS and SS. LcS intervention increased the Pseudobutyrivibrio and Roseburia abundances in HS and decreased the Pseudobutyrivibrio abundance in SS.
CONCLUSIONS
LcS supplementation improved the constipation-related symptoms in constipated subjects. Differences in baseline stool consistency could result in different anti-constipation effects of LcS intervention. LcS balanced the stool consistency"”softened the HS and hardened the SS. These effects could be associated with modulation of the gut microbiota and SCFA production.

Keyword

Constipation; Fatty acids, volatile; Gastrointestinal microbiome; Lactobacillus casei

MeSH Terms

Beverages
China*
Constipation*
Defecation
Fatty Acids, Volatile
Gastrointestinal Microbiome
Humans
Lactobacillus casei*
Lactobacillus*
Probiotics
Stem Cells
Fatty Acids, Volatile
Full Text Links
  • JNM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr